SMYD3 and ovarian carcinoma: Interestingly, attenuating the expression of SMYD3 and ITGB6 also decreased the release of latent TGFβ1 from ovarian cancer spheroids, which further demonstrated the regulatory roles of SMYD3 and ITGB6 in TGFβ1 pathway activation.